Key facts
- Scindo’s last known valuation is $17.6M (Sep 2025).
- It has raised $7.6M; the latest was Later Stage VC ($6.4M) in Sep 2025.
- Notable investors include Plug and Play Tech Center, Innovate UK, SOSV, IndieBio, Asymmetry Ventures — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Scindo
- ·The full record, as it builds
Funding rounds
No funding rounds for Scindo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scindo
Developer of an enzyme discovery and design platform designed to create the next generation of biocatalysts for the future of sustainable manufacturing. The company's platform transforms low-value waste products into high-value compounds and its enzymes facilitate direct pathways between natural and renewable, or upcycled feedstocks and bioactive ingredients that are used in your daily lives, from cosmetics and personal care to nutrients and food, enabling clients and other parties with a viable alternative to landfills and incineration.
- Sector
- Business Products and Services (B2B)
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 9
- Website
- scindo.bio/
- Ownership
- Privately Held (backing)
Scindo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scindo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scindo in its N-PORT filings yet. We sweep new filings monthly.